NB
NBTK.F Invesco NASDAQ Biotech UCITS ETF
- EUR
No recent price
- Total assets
- 561M
- Expense ratio
- 0.39%
- Dividend yield
- 0.87%
- 1-year return
- +43.59%
- Holdings
- 1
- Since
- 2014
Fund data as reported by the issuer, updated Nov 11, 2026. Total assets are in the fund's base currency.
What does NBTK.F invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (91.1%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (97.9%)
Asset allocation
- US stocks 91.1%
- Non-US stocks 7.3%
Invesco NASDAQ Biotech UCITS ETF performance
Sharpe ratio 0.92- This year
- +34.65%
- 1 year
- +43.59%
- 3 years
- +24.38%
- 5 years
- +9.42%
Volatility 18.1% over 1 year and 18.5% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
NBTK.F price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Invesco NASDAQ Biotech UCITS ETF top holdings
The holdings of Invesco NASDAQ Biotech UCITS ETF are not available yet.
NBTK.F sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
NBTK.F regional exposure
- North America97.9%
- Europe Developed4.0%
- United Kingdom2.3%
- Asia Developed0.1%
- Asia Emerging0.1%
- Australasia0.1%
- Africa/Middle East0.0%
Share of the stocks in the fund.
Company size
Average market cap 22.9B- Mega cap0.6%
- Big cap27.1%
- Medium cap35.3%
- Small cap25.9%
- Micro cap11.1%
Invesco NASDAQ Biotech UCITS ETF fund profile
- Fund name
- Invesco NASDAQ Biotech UCITS ETF
- Ticker
- NBTK.F
- Exchange
- Frankfurt Exchange
- Issuer
- Invesco Investment Management Limited
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Inception date
- Nov 6, 2014
- Trading currency
- EUR
- Expense ratio
- 0.39%